GILD · US market

Gilead Sciences Inc

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$182.89bnFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E-56.45×
Latest-quarter run-rate P/E-4.36×
Trailing P/S6.00×
Latest-quarter run-rate P/S5.86×

Calculation inputs

Trailing earnings
-US$3.24bn
Latest-quarter run-rate earnings
-US$41.98bn
Latest fiscal-year earnings
US$8.51bn
Trailing revenue
US$30.46bn
Latest-quarter run-rate revenue
US$31.21bn
Latest fiscal-year revenue
US$29.44bn

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

  • BBH · VanEck Biotech ETF12.79% weight · Holdings dated 30 June 2026
  • IBB · iShares Biotechnology ETF7.02% weight · Holdings dated 19 August 2026
  • BMED · iShares Health Innovation Active ETF4.89% weight · Holdings dated 21 August 2026
  • PJP · Invesco Pharmaceuticals ETF4.70% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • IBBQ · Invesco Nasdaq Biotechnology ETF4.62% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • PBE · Invesco Biotechnology & Genome ETF4.62% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • TMED · T. Rowe Price Health Care ETF4.44% weight · Holdings dated 30 June 2026
  • SHSSX · BlackRock Health Sciences Opportunities Portfolio Institutional Shares4.19% weight · Holdings dated 29 May 2026
  • POGSX · Pin Oak Equity Fund3.90% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • LOGSX · Live Oak Health Sciences Fund3.54% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.